Does EDARAVONE Cause Salivary hypersecretion? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Salivary hypersecretion have been filed in association with EDARAVONE (edaravone). This represents 0.2% of all adverse event reports for EDARAVONE.
9
Reports of Salivary hypersecretion with EDARAVONE
0.2%
of all EDARAVONE reports
1
Deaths
1
Hospitalizations
How Dangerous Is Salivary hypersecretion From EDARAVONE?
Of the 9 reports, 1 (11.1%) resulted in death, 1 (11.1%) required hospitalization.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EDARAVONE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does EDARAVONE Cause?
Death (707)
Disease progression (309)
Drug ineffective (292)
Amyotrophic lateral sclerosis (199)
Fatigue (174)
Asthenia (157)
Condition aggravated (147)
Muscular weakness (138)
Dyspnoea (136)
Gait disturbance (111)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which EDARAVONE Alternatives Have Lower Salivary hypersecretion Risk?
EDARAVONE vs EDETATE
EDARAVONE vs EDOXABAN
EDARAVONE vs EDOXABAN TOSILATE
EDARAVONE vs EFALIZUMAB
EDARAVONE vs EFANESOCTOCOG ALFA